Literature DB >> 14573779

Gene expression profiling during all-trans retinoic acid-induced cell differentiation of acute promyelocytic leukemia cells.

Lijun Yang1, Hongshan Zhao, Shi-Wu Li, Kim Ahrens, Christine Collins, Sarah Eckenrode, Qing-guo Ruan, Richard A McIndoe, Jin-Xiong She.   

Abstract

Using cDNA microarrays we determined the gene expression patterns in the human acute promyelocytic leukemia (APL) cell line NB4 during all-trans retinoic acid (ATRA)-induced differentiation. We analyzed the expression of 12,288 genes in the NB4 cells after 12 hours, 24 hours, 48 hours, 72 hours, and 96 hours of ATRA exposure. During this time course, we found 168 up-regulated and more than 179 down-regulated genes, most of which have not been reported before. Many of the altered genes encode products that participate in signaling pathways, cell differentiation, programmed cell death, transcription regulation, and production of cytokines and chemokines. Of interest, the CD52 and protein kinase A regulatory subunit alpha (PKA-Rlalpha) genes, whose products are being used as therapeutic targets for certain human neoplasias in currently ongoing clinical trials, were among the genes observed to be markedly up-regulated after ATRA treatment. The present study provides valuable data to further understand the mechanism of ATRA-induced APL cell differentiation and suggests potential therapeutic alternatives for this leukemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14573779      PMCID: PMC1907337          DOI: 10.1016/S1525-1578(10)60476-X

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  53 in total

1.  Signal transduction pathways underlying the expression of tissue factor and thrombomodulin in promyelocytic cells induced to differentiate by retinoid acid and dibutyryl cAMP.

Authors:  C López-Pedrera; P M Dobado-Berrios; R Ros; A Torres; S García-Navarro; M Jardí; J Félez; F Velasco
Journal:  Thromb Haemost       Date:  2001-06       Impact factor: 5.249

2.  Neutrophils produce biologically active macrophage inflammatory protein-3alpha (MIP-3alpha)/CCL20 and MIP-3beta/CCL19.

Authors:  P Scapini; C Laudanna; C Pinardi; P Allavena; A Mantovani; S Sozzani; M A Cassatella
Journal:  Eur J Immunol       Date:  2001-07       Impact factor: 5.532

Review 3.  Disseminated intravascular coagulation in acute leukemia.

Authors:  T Barbui; A Falanga
Journal:  Semin Thromb Hemost       Date:  2001-12       Impact factor: 4.180

4.  Quantitative monitoring of gene expression patterns with a complementary DNA microarray.

Authors:  M Schena; D Shalon; R W Davis; P O Brown
Journal:  Science       Date:  1995-10-20       Impact factor: 47.728

5.  [Effects of all-trans retinoic acid and arsenic trioxide on tissue factor expression of acute promyelocytic leukemia cells].

Authors:  W Guo; H Wang; W Zhao
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2000-05

6.  Urokinase plasminogen activator and plasmin efficiently convert hemofiltrate CC chemokine 1 into its active.

Authors:  J Vakili; L Ständker; M Detheux; G Vassart; W G Forssmann; M Parmentier
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

7.  Phosphorylation of the cytoplasmic domain of the integrin CD18 chain by protein kinase C isoforms in leukocytes.

Authors:  Susanna Fagerholm; Nick Morrice; Carl G Gahmberg; Philip Cohen
Journal:  J Biol Chem       Date:  2001-11-07       Impact factor: 5.157

Review 8.  Orchestration of multiple arrays of signal cross-talk and combinatorial interactions for maturation and cell death: another vision of t(15;17) preleukemic blast and APL-cell maturation.

Authors:  G Benoit; M Roussel; F Pendino; E Ségal-Bendirdjian; M Lanotte
Journal:  Oncogene       Date:  2001-10-29       Impact factor: 9.867

9.  UBE1L is a retinoid target that triggers PML/RARalpha degradation and apoptosis in acute promyelocytic leukemia.

Authors:  Sutisak Kitareewan; Ian Pitha-Rowe; David Sekula; Christopher H Lowrey; Michael J Nemeth; Todd R Golub; Sarah J Freemantle; Ethan Dmitrovsky
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

10.  Regulatory subunit type I-alpha of protein kinase A (PRKAR1A): a tumor-suppressor gene for sporadic thyroid cancer.

Authors:  Fabiano Sandrini; Ludmila Matyakhina; Nicholas J Sarlis; Lawrence S Kirschner; Constantine Farmakidis; Oliver Gimm; Constantine A Stratakis
Journal:  Genes Chromosomes Cancer       Date:  2002-10       Impact factor: 5.006

View more
  12 in total

Review 1.  Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.

Authors:  Adam Lerner; Paul M Epstein
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

2.  A novel network pharmacology approach for leukaemia differentiation therapy using Mogrify®.

Authors:  Lin Ming Lee; Eleni G Christodoulou; Pavithra Shyamsunder; Bei Jun Chen; Kian Leong Lee; Tsz Kan Fung; Chi Wai Eric So; Gee Chuan Wong; Enrico Petretto; Owen J L Rackham; S Tiong Ong
Journal:  Oncogene       Date:  2022-10-21       Impact factor: 8.756

3.  Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist.

Authors:  Michael R McKeown; M Ryan Corces; Matthew L Eaton; Chris Fiore; Emily Lee; Jeremy T Lopez; Mei Wei Chen; Darren Smith; Steven M Chan; Julie L Koenig; Kathryn Austgen; Matthew G Guenther; David A Orlando; Jakob Lovén; Christian C Fritz; Ravindra Majeti
Journal:  Cancer Discov       Date:  2017-07-20       Impact factor: 39.397

4.  Additive effects of PI3-kinase and MAPK activities on NB4 cell granulocyte differentiation: potential role of phosphatidylinositol 3-kinase gamma.

Authors:  Sebastian Scholl; Tzvetanka Bondeva; Yuantao Liu; Joachim H Clement; Klaus Höffken; Reinhard Wetzker
Journal:  J Cancer Res Clin Oncol       Date:  2008-02-21       Impact factor: 4.553

5.  Src family kinase gene targets during myeloid differentiation: identification of the EGR-1 gene as a direct target.

Authors:  J E Jones; L Wang; P L Kropf; R Duan; D E Johnson
Journal:  Leukemia       Date:  2009-06-04       Impact factor: 11.528

6.  G0S2 is an all-trans-retinoic acid target gene.

Authors:  Sutisak Kitareewan; Steven Blumen; David Sekula; Reid P Bissonnette; William W Lamph; Qingping Cui; Robert Gallagher; Ethan Dmitrovsky
Journal:  Int J Oncol       Date:  2008-08       Impact factor: 5.650

7.  Belinostat, a potent HDACi, exerts antileukaemic effect in human acute promyelocytic leukaemia cells via chromatin remodelling.

Authors:  Giedre Valiuliene; Ieva Stirblyte; Dovile Cicenaite; Algirdas Kaupinis; Mindaugas Valius; Ruta Navakauskiene
Journal:  J Cell Mol Med       Date:  2015-04-11       Impact factor: 5.310

Review 8.  ISG15 and immune diseases.

Authors:  Young Joo Jeon; Hee Min Yoo; Chin Ha Chung
Journal:  Biochim Biophys Acta       Date:  2010-02-12

9.  Molecular recognition of acute myeloid leukemia using aptamers.

Authors:  K Sefah; Z W Tang; D H Shangguan; H Chen; D Lopez-Colon; Y Li; P Parekh; J Martin; L Meng; J A Phillips; Y M Kim; W H Tan
Journal:  Leukemia       Date:  2009-01-08       Impact factor: 11.528

10.  Applications of microarray technology to Acute Myelogenous Leukemia.

Authors:  Rashmi S Goswami; Mahadeo A Sukhai; Mariam Thomas; Patricia P Reis; Suzanne Kamel-Reid
Journal:  Cancer Inform       Date:  2008-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.